title: Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock.
abstract: Anandamide, an endogenous cannabinoid ligand, binds to CB1 cannabinoid receptors in the brain and mimics the neurobehavioural actions of marijuana. Cannabinoids and anandamide also elicit hypotension mediated by peripheral CB1 receptors. Here we report that a selective CB1 receptor antagonist, SR141716A, elicits an increase in blood pressure in rats subjected to haemorrhagic shock, whereas similar treatment of normotensive rats or intracerebroventricular administration of the antagonist during shock do not affect blood pressure. Blood from haemorrhaged rats causes hypotension in normal rats, which can be prevented by SR141716A but not by inhibition of nitric oxide synthase in the recipient. Macrophages and platelets from haemorrhaged rats elicit CB1 receptor-mediated hypotension in normotensive recipients, and incorporate arachidonic acid or ethanolamine into a product that co-elutes with anandamide on reverse-phase high-performance liquid chromatography. Also, macrophages from control rats stimulated with ionomycin or bacterial phospholipase D produce anandamide, as identified by gas chromatography and mass spectrometry. These findings indicate that activation of peripheral CB1 cannabinoid receptors contributes to haemorrhagic hypotension, and anandamide produced by macrophages may be a mediator of this effect.
authors.affiliation: Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298, USA.
authors.forename: J A
authors.initials: JA
authors.lastname: Wagner
authors.forename: K
authors.initials: K
authors.lastname: Varga
authors.forename: E F
authors.initials: EF
authors.lastname: Ellis
authors.forename: B A
authors.initials: BA
authors.lastname: Rzigalinski
authors.forename: B R
authors.initials: BR
authors.lastname: Martin
authors.forename: G
authors.initials: G
authors.lastname: Kunos
mesh_terms: D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism; D016913:Blood Component Transfusion; D001794:Blood Pressure; D001803:Blood Transfusion; D002186:Cannabinoids / Q000037:antagonists & inhibitors / Q000378:metabolism*; D002478:Cells, Cultured; D002851:Chromatography, High Pressure Liquid; D063388:Endocannabinoids; D008401:Gas Chromatography-Mass Spectrometry; D008264:Macrophages / Q000378:metabolism; D008297:Male; D009000:Monocytes / Q000378:metabolism / Q000637:transplantation; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000378:metabolism; D010880:Piperidines / Q000494:pharmacology; D053284:Polyunsaturated Alkamides; D011720:Pyrazoles / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug / Q000378:metabolism*; D000077285:Rimonabant; D012771:Shock, Hemorrhagic / Q000378:metabolism*
chemical_list: D001095:Arachidonic Acids; D002186:Cannabinoids; D063388:Endocannabinoids; D010880:Piperidines; D053284:Polyunsaturated Alkamides; D011720:Pyrazoles; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug; D019001:Nitric Oxide Synthase; D000077285:Rimonabant; C078814:anandamide